Feasibility, safety and dosimetry of intramural administration of 32P-oligonucleotide-mediating beta-particle delivery to prevent restenosis.
Fareh
J
Angiogene Inc., Centre Hospitalier de l'Université de Montréal, Montreal, Quebec, Canada
Martel
R
Leclerc
G